Expertise in

conditions

Volkmar Falk

Zurich, ZH, CH

Clinical Trials:Currently Recruiting for 1 Trial

Expertise in

conditions

Zurich, ZH, CH

Overview

Volkmar Falk practices in Zurich, Switzerland. Falk is highly rated in 28 conditions, according to our data. Their top areas of expertise are Aortic Regurgitation, Aortic Valve Stenosis, Mitral Valve Regurgitation, Transcatheter Aortic Valve Replacement (TAVR), and Heart Bypass Surgery.

Their clinical research consists of co-authoring 689 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

Zurich, ZH, Switzerland

Other Locations

Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

Enrollment Status: Recruiting

Publish Date: January 20, 2026

Intervention Type: Drug

Study Drugs: Antiplatelet-only strategy, Anticoagulant+Background antiplatelet therapy

Study Phase: Phase 3

Evaluating the Benefit of Concurrent Tricuspid Valve Repair During Mitral Surgery

Enrollment Status: Completed

Publish Date: June 18, 2024

Intervention Type: Procedure

Study Phase: Not Applicable

Randomized, Multi-Center, Event-Driven Trial of TAVI Versus SAVR in Patients With Symptomatic Severe Aortic Valve Stenosis and Intermediate Risk of Mortality, as Assessed by STS-Score - DEDICATE

Enrollment Status: Active_not_recruiting

Publish Date: April 26, 2024

Intervention Type: Device, Procedure

Study Phase: Not Applicable

Operative Mitralklappenrekonstruktion Bei Funktionellen Mitralklappenvitien Bei Reduzierter Systolischer Ventrikelfunktion

Enrollment Status: Completed

Publish Date: September 28, 2023

Intervention Type: Procedure

The RELIEF Trial: REduction or eLimination of mItral rEgurgitation in Degenerative or Functional Mitral Regurgitation With the CardiAQ-Edwards™ Transcatheter Mitral Valve

Enrollment Status: Withdrawn

Publish Date: January 09, 2018

Intervention Type: Device

Study Phase: Phase 1/Phase 2

View 4 Less Clinical Trials

689 Total Publications

The first European remote robotic heart surgery.

Journal: European heart journal

Published: April 09, 2026

View All 689 Publications

Frequently Asked Questions about Volkmar Falk

Is Volkmar Falk a top-rated expert for Transcatheter Aortic Valve Replacement (TAVR)?

MediFind is an objective health platform that identifies experts based on real-world data. Volkmar Falk is classified as an Elite expert for Transcatheter Aortic Valve Replacement (TAVR), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Volkmar Falk participate in research or clinical trials?

Yes. Volkmar Falk has published 689 articles and abstracts on conditions like Transcatheter Aortic Valve Replacement (TAVR). You can view a list of Volkmar Falk's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Falk's expertise for a condition

ConditionClose